A recent study showed that hepatocyte-specific deletion of Mettl3 drives NAFL-to-NASH progression by increasing CD36-mediated hepatic free fatty acid uptake and CCL2-induced inflammation (37). Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.